Maximizing Performance Into Brand Maturity
Thursday, December 3 | 1:00PM ET
After the launch year ends, many pharma brands face a new and underestimated risk: momentum loss. Budgets tighten, senior leadership attention shifts to the next launch, and experienced team members move on — all while competitive threats continue to mount. For market access teams managing an established brand, staying vigilant is not optional. Every access percentage point lost costs more to recover than it did to keep.
In this webinar, our experts discuss the strategies and tools that help teams protect and grow brand performance through the full patent lifecycle — from defending preferred status in a competitive class to expanding coverage across new indications, and finally, preparing for loss of exclusivity before it arrives.
You will Learn how to:
- Maintain preferred access, monitor competitive entrants, and respond before your payer position erodes
- Surface coverage information to HCPs and patients to sustain prescribing momentum
- Leverage market intelligence and AI to track payer sentiment, identify threats, and stay ahead with fewer resources
- Maximize brand value and patient reach through the full patent lifecycle and plan ahead for LOE
Register for the Webinar
Our Experts
Alexandra (Alex) Myers
Vice President, Client Partnership, MMIT
Alexandra (Alex) Myers is a vice president of Client Partnership at MMIT who advises life sciences organizations navigating the market access landscape. With two decades of industry experience, Alex’s expertise spans both consulting and client-side partnership roles. Prior to MMIT, she worked at several Managed Markets consulting firms, including Eversana and Syneos Health. She holds a Bachelor of Science degree in Pharmaceutical Marketing from St. Joseph’s University.
Carolyn Zele
Advisor, Solution Consulting, MMIT
Carolyn Zele is an advisor for MMIT’s Solution Consulting team who helps pharmaceutical manufacturers simplify market access and prepare for launch success. Prior to MMIT, Carolyn spent numerous years in the payer/PBM space managing formulary teams and technology across both regulated and non-regulated lines of business. She holds a Master of Science degree from Colorado State University.